arrow
S

Sara MacLennan

Tata Memorial Hospital
H指数:28
被引数:3,204

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortium”. [Lung Cancer 205 (2025) 108610]

勘误:“OPTIMA联盟对肺癌管理临床实践指南的AGREE-II评估”[Lung Cancer 205 (2025) 108610]。

2025-07-080
OA
AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortium

OPTIMA联盟对肺癌管理临床实践指南的AGREE-II评估

2025-06-030
OA
How Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?

我们如何改善诊断为前列腺癌的男性患者与临床医生的沟通?

2024-04-010
OAAI
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium
2023-04-036
OA
Secondary Treatment for Men with Localized Prostate Cancer: A Pooled Analysis of PRIAS and ERSPC-Rotterdam Data within the PIONEER Data Platform
2022-05-052
OAAI
Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium
2022-05-0121
OA
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review

标准化局部前列腺癌患者报告结局指标的评估。系统回顾

2022-04-0120
OA
The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer

患者参与前列腺癌核心结果集开发的关键作用

2021-09-015
OAAI